An increasing number of scientists over recent years have dared to speak up regarding the obsolescence of chemotherapy. Although their hope is usually for adequately targeted gene therapy, which is a dead-end, as explained in Chapter 9 of Manifesto for a Cancer Patient, it is an acknowledgment of the unacceptable problems of chemotherapy. I have even heard a number of chemotherapy oncologists admit this in medical conferences in small conversations with their colleagues. Dwight McKee MD is one of the few medical oncologists to go on record with this prediction.i

Modern chemotherapy was born in World War II, November 30, 1943, in Bari, Italy. The event was an air attack by the Luftwaffe on Allied warships. Unfortunately, one such ship was stockpiled with an agent of chemical warfare: mustard gas, despite an agreement by both sides not to use war gasses. As Allied servicemen found themselves blown from their ship and into the now contaminated water, an oily residue clung to their skin and clothes. Over the next few days, following rescue from the cold water, they complained of burning skin and blindness. One thousand Allied servicemen lost their lives from this exposure.

Over the next few days after the attack it was discovered that another effect of this gas exposure on the men was that their white blood cells were greatly reduced. Later, the same chemical was then given deliberately and experimentally to lymphoma and leukemia patients, and it was discovered that their cancer burden regressed considerably. This discovery was especially exciting, because conventional medicine had not yet offered any effective treatment at all for any cancer, except for radical surgery and radiation. Neither of those was applicable to such an elusive and scattered blood disease, such as the leukemias. So here was something that appeared to be a viable and promising alternative.